Genetics-testing company 23andMe has warned there is “substantial doubt” over its continued survival unless it raises new ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
23andMe posted a narrower loss in its fiscal second quarter, the day after announcing it would cut 40% of its workforce and discontinue its pipeline of therapeutics.
23andMe is shutting down its therapeutics development division and plans to seek out buyers to find a new home for its ...
SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...
Me Holding Co.’s stock turned down early Tuesday, after the DNA-testing company reported fiscal second-quarter earnings, a ...
23andMe, the genetic testing firm backed by Richard Branson's VG Acquisition Corp, has announced plans to lay off 200 ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.